StockWatch
·
Biotechnology: Pharmaceutical Preparations
Corporate ActionNov 6, 2026, 05:16 PM

BioVie Inc. Raises $4.74M Via Stock and Warrant Offering

AI Summary

BioVie Inc. announced the pricing of a $4.74 million registered direct offering and concurrent private placement. The offering involved the sale of 960,000 shares of common stock at $1.60 per share and 2,002,500 pre-funded warrants at $1.5999 each. Additionally, 2,962,500 common warrants were issued in a private placement with an exercise price of $1.70. The company intends to use the net proceeds for working capital and general corporate purposes. A.G.P./Alliance Global Partners served as the sole placement agent.

Key Highlights

  • BioVie Inc. raised approximately $4.74 million in a registered direct offering and concurrent private placement.
  • The offering included 960,000 shares of Class A common stock at $1.60 per share.
  • The company also issued 2,002,500 pre-funded warrants at $1.5999 each.
  • In a concurrent private placement, 2,962,500 common warrants were issued with an exercise price of $1.70.
  • Proceeds will be used for working capital and general corporate purposes.
  • A.G.P./Alliance Global Partners acted as the exclusive placement agent for the offering.